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Vascular Medicine 2006; 11: 259–262Acute lower limb ischemia due to thrombo-embolic 
arterial occlusions in two previously healthy men with
markedly elevated Lp(a)
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© 2006 SAGE PuAbstract: Lipoprotein (a) (Lp(a)) is a well-documented risk factor for atherosclerotic
cardiovascular disease. Its role in acute thrombo-embolic occlusions of peripheral
arteries is not known. We describe two cases of multiple, acute, peripheral arterial
occlusions in two previously healthy men with markedly elevated Lp(a). Both cases
had unsatisfactory results after percutaneous and surgical revascularization proce-
dures. Experience yielded in these two cases suggests that when an unfavorable out-
come occurs in a peripheral artery disease patient in the absence of the regular risk
factors, Lp(a) should be determined and its role investigated.Key words: acute limb ischemia; arterial thrombosis; Lp(a); myointimal hyperplasia;
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previously healthy white male presented
ith a 3-week history of right-sided calf
and foot claudication. His past medical history was
significant only for a recently developed impotence,
for which he had received three monthly testosterone
injections. He had no history of smoking, diabetes,
hypertension, hypercholesterolemia, and no family
history of premature cardiovascular disease.
The physical examination and non-invasive vascular
laboratory tests showed bilateral, distal PAD with
impaired hemodynamic function at the level of the
right calf and left foot. Duplex ultrasound showed
hypoechogenic occlusion of the right popliteal artery
in the absence of arteriosclerosis or aneurysm. The
patient underwent an extensive work-up including a
24-hour Holter monitor, transesophageal echocardio-
gram and aortic imaging to rule out embolic disease.
Laboratory tests including markers of inflammation
(ESR, CRP), electrophoresis, antinuclear and anticar-
diolipin antibodies and tests for thrombophilia (fib-
rinogen, ATIII, protein C and S, activated protein C)
were normal. Homocysteine was 13.2 mol/l (normal
values 13.9 mol/l). Lipid and lipoprotein analysis
showed normolipidemia (total cholesterol 203 mg/dl,
LDL-cholesterol 120 mg/dl, HDL-cholesterol 55 mg/dl,
triglycerides 153 mg/dl). Lp(a) was measured with a
commercial turbidometric immunoassay (Wako, Japan)
with a normal reference range of 30 mg/dl and it was
markedly elevated at 86 mg/dl.
Digital subtraction angiography (DSA) showed
occlusion of the popliteal artery of the right leg
(Figure 1), and occlusion of the posterior and anterior
tibial arteries of the left leg with thrombo-embolic
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appearance. Percutaneous recanalization of the right
popliteal artery was attempted by catheter-directed
thrombolysis with urokinase followed by aspiration
thrombectomy and percutaneous transluminal angio-
plasty (PTA). All procedures were unsuccessful. The
patient was treated with oral anticoagulation and 
walking exercise. After 3 months the patient showed
marked symptomatic and hemodynamic improvement.
Case 2
A 54-year-old, previously healthy white male pre-
sented at another hospital with acute, critical ischemia
of the right leg. Angiography revealed occlusions of
the right common and external iliac artery (Figure 2A)
and of the left tibio-peroneal trunk. Surgical
thrombectomy of the right iliac artery required two
interventions because of early re-occlusion, and was
unsuccessful in the left tibio-peroneal trunk. He
underwent an extensive work-up including a 24-hour
Holter monitor, transesophageal echocardiogram and
aortic imaging to rule out embolic disease. At the time
of discharge from the hospital ankle–brachial indices
were normal and walking distance unlimited.
The patient was first seen at our clinic 8 months
later complaining of a 5-month history of bilateral calf
claudication. He had no history of diabetes, hyperten-
sion, hypercholesterolemia, and no family history of
cardiovascular disease. He had quit smoking 1 year
previously after a 12-pack year history.
Physical examination and non-invasive vascular
laboratory tests showed bilateral PAD with impaired
hemodynamic function at the level of the right thigh
and left calf. Laboratory tests including markers of
inflammation (ESR, CRP), electrophoresis, anti-
nuclear and anticardiolipin antibodies and tests for
thrombophilia (fibrinogen, ATIII, protein C and S,
activated protein C) were normal. Homocysteine was
9.2 mol/l (normal values 13.9 mol/l). Lipid and
lipoprotein analysis showed a borderline hypercholes-
terolemia (total cholesterol 209 mg/dl, LDL-C
147 mg/dl, HDL-C 40 mg/dl, triglycerides 108 mg/dl).
Lp(a), measured with a commercial turbidometric
Figure 1 Digital subtraction angiography of the right
leg in patient 1: occlusion of the popliteal artery at the
level of the knee joint space and of the proximal crural
vessels with thrombo-embolic appearance.
Figure 2 Digital subtraction angiography of the aortoil-
iac vessels in patient 2 at the time of initial presentation
(A), and 8 months after surgical revascularization (B).
The first angiogram shows acute, thrombo-embolic
occlusion of the right iliac arteries, and the second
angiogram shows high-grade, myointimal restenosis.
 at LMU Muenchen on June 17, 2013vmj.sagepub.comDownloaded from 
Acute lower limb ischemia with elevated Lp(a) 261
Vascular Medicine 2006; 11: 259–262
immunoassay (Wako), was markedly elevated at
81 mg/dl (normal 30 mg/dl).
DSA performed at an outside facility a few days
prior to presentation showed diffuse, high-grade
restenosis of the right common and external iliac
artery (Figure 2B), and of the left popliteal artery.
Duplex ultrasound showed circular, hypoechogenic
wall thickening in the affected arteries consistent with
myointimal hyperplasia. We recommended PTA of the
right iliac artery. The patient wished to undergo the
intervention at an outside facility and was lost to 
follow-up. From a telephone contact, he is experienc-
ing persistent bilateral claudication despite repeated
interventions.
Discussion
We present the cases of two men with severe PAD due
to multiple, thrombo-embolic arterial occlusions in the
absence of advanced arteriosclerosis and traditional
cardiovascular risk factors. Markedly elevated Lp(a)
above 80 mg/dl was identified as the only significant
laboratory abnormality. The morphology of the occlu-
sions and the acute onset of symptoms suggest either
embolism or local arterial thrombosis. A source of
embolism could not be identified. However, embolism
of unknown origin remains a possibility. Other etiolo-
gies of non-arteriosclerotic PAD such as thrombangi-
itis obliterans, large-vessel vasculitis, or popliteal
entrapment have either been ruled out or appear very
unlikely based on the clinical presentation and vascu-
lar morphology.
Elevated Lp(a) is a well-established risk factor for
cardiovascular disease2 and it has also been shown to
be a strong predictor of peripheral vascular disease,
independently of cigarette smoking and diabetes in a
group of 100 white male patients with mean age of 67
years.5 In a case–control study of 50 white men under
the age of 45 years with PAD, an elevated Lp(a) 
(30 mg/dl) was an independent risk factor for the
development of premature peripheral vascular disease.
No association was found for homocysteine, antiphos-
pholipid antibodies, antithrombin III, and protein C
and S.6 In a similar retrospective study in 55 white
men, an elevated Lp(a) was specifically and independ-
ently associated with premature PAD but not with pre-
mature coronary artery disease.3 However, patients in
these studies presumably had arteriosclerotic PAD. To
our knowledge this is the first report of highly elevated
Lp(a) in patients with an initial diagnosis of PAD due
to acute arterial thrombo-embolic occlusions.
The structural homology of apolipoprotein (a) with
plasminogen confers Lp(a) unique antifibrinolytic and
prothrombotic properties.1,4 Several lines of evidence
suggest that Lp(a) may be a risk factor for thrombotic
vascular disorders unrelated to arteriosclerosis.
Elevated Lp(a) has been linked to venous 
thrombo-embolism,7 childhood ischemic stroke,8 left
atrial thrombus,9 and pregnancy loss.10
Another remarkable feature of the two presented
cases is the unsatisfactory outcome after percutaneous
and surgical vascular interventions. Elevated Lp(a) has
been previously recognized as a risk factor for short-
term, myointimal restenosis after interventions in
peripheral arteries.11 In a prospective study of 139 con-
secutive patients with successful PTA of the femoro-
popliteal area, the group who developed re-stenosis or
re-occlusion within 1 year had a higher Lp(a) than the
group without re-stenosis (59 vs 28 mg/dl). This was
independent of all other risk factors, which were equally
distributed between the two groups.12 Moreover, Lp(a)
has been shown to accumulate specifically at sites of 
initial myointimal hyperplasia in an animal model after
arterial injury caused by balloon angioplasty.13
Patient 1 received testosterone replacement therapy
prior to the occurrence of claudication. We cannot
exclude that the hormonal therapy was a precipitating
event for the thrombotic disease. The net effect of
testosterone on the cardiovascular risk profile is
unknown and both beneficial and deleterious effects
have been recorded.14 We found one report of acute
limb-threatening ischemia due to thrombosis of
femoropopliteal and crural arteries after treatment
with the synthetic androgen danazol, which was, how-
ever, mediated by severe thrombocytosis.15
Although our findings need to be confirmed in other
cases, we believe that markedly elevated Lp(a) may
have played an important causative role in the pre-
sented two cases of acute PAD due to thrombo-
embolic arterial occlusions. We suggest that it may be
worthwhile to measure Lp(a) in young patients with
PAD with unexplained, acute, arterial occlusions and
lack of other traditional risk factors.
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